Overview

A class action lawsuit has been filed against Orthofix Medical, Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) and certain of the Company’s former senior executive officers alleging violations of the federal securities laws.  The Orthofix class action lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired common stock between October 11, 2022, and September 12, 2023, both dates inclusive (the “Class Period”).  Investors have until October 21, 2024, to seek appointment as lead plaintiff of the Orthofix class action lawsuit.

Orthofix is a global spine and orthopedics company that offers biologics, spinal hardware, bone growth therapies, and specialized orthopedic solutions, among other things, to healthcare professionals throughout the world.

The Orthofix class action lawsuit alleges that Defendants, throughout the Class Period, made misleading statements and omissions regarding the Company’s business, financial condition, and prospects.  Specifically, Defendants failed to disclose that certain of the Company’s management team had engaged in repeated inappropriate and offensive conduct.  As the truth about adverse facts concerning the Company’s management team reached the market, the price of Orthofix’s common stock suffered significant declines, harming investors.  For example, on September 12, 2023, Orthofix announced the unanimous decision by its Board’s independent directors to terminate and replace the offending members of the Company’s management team.  On this news, the Company’s stock declined $5.62 per share, or over 30%, to close at $13.01 per share on September 13, 2023, on unusually heavy volume.

*          *          *

If you purchased or otherwise acquired Orthofix common stock between October 11, 2022, and September 12, 2023, both dates inclusive, and you wish to serve as lead plaintiff in this lawsuit, we encourage you to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at [email protected]. 

The deadline to apply to the Court to serve as a lead plaintiff in the Orthofix class action lawsuit is October 21, 2024.